Comparison 2. Consultation liaison versus collaborative care.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Improvement	1		Risk Difference (M‐H, Fixed, 95% CI)	Totals not selected
1.1 up to 3 months	1		Risk Difference (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
1.2 from 3 to 12 months	1		Risk Difference (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
2 Symptoms	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
2.1 up to 3 months	1		Mean Difference (IV, Fixed, 95% CI)	0.0 [0.0, 0.0]
2.2 from 3 to 12 months	1		Mean Difference (IV, Fixed, 95% CI)	0.0 [0.0, 0.0]
3 Consumer satisfaction	1		Risk Difference (M‐H, Fixed, 95% CI)	Totals not selected
3.1 up to 3 months	1		Risk Difference (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3.2 from 3 to 12 months	1		Risk Difference (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
4 Disability	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
4.1 up to 3 months	1		Mean Difference (IV, Fixed, 95% CI)	0.0 [0.0, 0.0]
4.2 from 3 to 12 months	1		Mean Difference (IV, Fixed, 95% CI)	0.0 [0.0, 0.0]
5 General health	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
5.1 up to 3 months	1		Mean Difference (IV, Fixed, 95% CI)	0.0 [0.0, 0.0]
5.2 from 3 to 12 months	1		Mean Difference (IV, Fixed, 95% CI)	0.0 [0.0, 0.0]
6 Loss to follow‐up	1		Risk Difference (M‐H, Fixed, 95% CI)	Totals not selected
6.1 up to 3 months	1		Risk Difference (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
6.2 from 3 to 12 months	1		Risk Difference (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
7 Received adequate treatment	1		Risk Difference (M‐H, Fixed, 95% CI)	Totals not selected
7.1 from 3 to 12 months	1		Risk Difference (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
8 Prescribing	1		Risk Difference (M‐H, Fixed, 95% CI)	Totals not selected
8.1 from 3 to 12 months	1		Risk Difference (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]